A twelve-week-old female intact golden retriever weighing 6 kg was referred with an 8-week history of recurring episodes of muscle stiffness and collapse. Episodes were most often triggered by excitement and exercise. An episode began with a stiff gait and arched spine progressing to holding the head down and raising the rear. Finally, the dog collapsed with all four limbs extended (Figure 1a-i) . After removal of the triggering factor, muscle tone returned to normal and the episode ended. Mentation was normal and abnormal autonomous activity was not present during the entire episode. The dog appeared to be completely normal immediately before and after the event. Frequency of episodes varied from 1-8 per day.
A twelve-week-old female intact golden retriever weighing 6 kg was referred with an 8-week history of recurring episodes of muscle stiffness and collapse. Episodes were most often triggered by excitement and exercise. An episode began with a stiff gait and arched spine progressing to holding the head down and raising the rear. Finally, the dog collapsed with all four limbs extended (Figure 1a -i). After removal of the triggering factor, muscle tone returned to normal and the episode ended. Mentation was normal and abnormal autonomous activity was not present during the entire episode. The dog appeared to be completely normal immediately before and after the event. Frequency of episodes varied from 1-8 per day.
Duration of the episodes varied from a few seconds to a maximum of ten minutes depending on the presence of the trigger.
On clinical examination a poor body condition score was noted (2/5). Complete neurological examination revealed generalized muscle atrophy. Patellar reflexes of both pelvic limbs were weak. During the neurological examination the puppy's gait was completely normal. Another puppy was introduced and an episode was triggered. The neurological syndrome was described as an excitement induced hypertonicity with involuntary muscle contractions. A neuromuscular disease or a CNS disorder resulting in a paroxysmal dyskinesia was suspected.
The results of a complete blood count (CBC), serum biochemistry and electrolyte analysis were within normal ranges and the pre-and postprandial bile acid concentrations were normal (Na 146 (146-153 mmol/l), K 4.2 (4.0-5.5 mmol/l), Cl 115 (105-117 mmol/l), Ca 2.63 (2.07-2.82 mmol/l), P 1.56 (1.00-1.93 mmol/l), urea 4.7 (1.2-8.5 mmol/l), creatinine 46 µmol/l (increased if > 60 plus bodyweight), total protein 64.9 (55.0-78.0 g/l), albumin 39 (22-44 g/l), AST 26 (<40 U/l), ALT 24 (<52 U/l), Gamma-GT 5 (<8 U/l), ALP 44 (< 123 U/l), bile acids (pre-prandial) 12 (< 19 µmol/l), bile acids (post-prandial) 5 (< 19 µmol/l) glucose 3.9 (3-5 mmol/l)).
Electromyography was performed during an episode of hypertonicity on the awake dog.
Normal motor unit action potentials were seen thereby excluding congenital myotonia.
Complete electrodiagnostic testing including electromyography, measurement of motor nerve conduction velocity and measurement of compound muscle action potential following repetitive nerve stimulation was performed under general anesthesia and no abnormalities were found. Muscle biopsies were collected from the cranial tibial, triceps and semitendinosus muscles and were either immersed into 10% buffered formalin or kept chilled and sent by an express service to a specialized laboratory. Upon receipt muscle biopsies were either flash frozen in isopentane precooled in liquid nitrogen or paraffin embedded. Type 2 fiber atrophy or hypotrophy was recognized using the myofibrillar ATPase reaction for fiber typing at pH . Here we describe a hypertonicity syndrome in a young female golden retriever. To the author's knowledge, no similar case in this breed has been reported to date.
The young age of onset at 3-4 months, episodes of hypertonicity and collapse, the normal behavior between episodes, the frequency and the duration of episodes which depended on the presence of a stressful triggering factor is similar to the hypertonicity syndromes that was previously described as episodic falling in the CKCS or cramping in the Scottish terrier (Meyers et al. 1970, Herrtage and Palmer 1983) . The diagnosis of a paroxysmal dyskinesia was based on the clinical signs that were inconsistent with epileptic seizures.
On neurological examination generalized muscle atrophy and weak patellar reflexes were found. To examine the neuromuscular part of the nervous system, an electrophysiological examination was performed. However, no abnormalities were detected, making a primary neuromuscular disease less likely. Histopathological examination of muscle biopsies excluded a primary myopathy. Myofiber size variation that could indicate variability in neuronal excitability was detected. In human medicine, some paroxysmal dyskinesias are caused by an ion channelopathy. An ion channelopathy can cause increased neuronal excitability that leads to paroxysmal dyskinesias (Wei et al. 2005) . Phenotypically the episodes of the puppy were similar to those of the CKCS with EFS. Therefore the puppy, the parents and the littermates were screened for the BCAN mutation that is associated with EFS in the CKCS. All dogs tested negative excluding the CKCS EFS microdeletion as a cause of this disorder. This finding does not rule out the possibility of another mutation in the BCAN gene resulting in this syndrome in the golden retriever. Further genetic testing including sequencing of the BCAN gene would be necessary to identify an underlying mutation.
The episodes in this case were triggered by excitement and stress, and as such, may be classified as PNKD. Avoiding excitement and stress could be part of the treatment but that would negatively affect the life quality of the dog. Therefore medical treatment was tested.
Clonazepam, a successful therapy in CKCS with EFS, was not successful in this case. It was reported that some CKCS with EFS responded to the carbonic anhydrase inhibitor acetazolamide, but information concerning this treatment is limited (Platt 2014 Acetazolamide in dogs is mainly used for non-neurological diseases as a diuretic and in glaucoma (Gelatt et al. 1979 ). Hyperchloremic metabolic acidosis and mild depletion of potassium is described in dogs treated with acetazolamide (Haskins et al. 1981) . No abnormalities, however, were seen on repeated blood examinations in this puppy. In human medicine, nephrolithiasis, hyperhidrosis, paresthesia, muscle stiffness and gastrointestinal disturbances are possible adverse effects of acetazolamide (Strupp et al. 2007 ).
In one report, long-term follow-up of two CKCS with EFS was described (Shelton 2004 
